000 01805 a2200445 4500
005 20250517074652.0
264 0 _c20180423
008 201804s 0 0 eng d
022 _a2048-7207
024 7 _a10.1093/jpids/piv064
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVesikari, Timo
245 0 0 _aImmunogenicity, Safety, and Tolerability of Bivalent rLP2086 Meningococcal Group B Vaccine Administered Concomitantly With Diphtheria, Tetanus, and Acellular Pertussis and Inactivated Poliomyelitis Vaccines to Healthy Adolescents.
_h[electronic resource]
260 _bJournal of the Pediatric Infectious Diseases Society
_cJun 2016
300 _a180-7 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
650 0 4 _aAdolescent
650 0 4 _aAntibodies, Bacterial
_xblood
650 0 4 _aDiphtheria-Tetanus-acellular Pertussis Vaccines
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunogenicity, Vaccine
650 0 4 _aMale
650 0 4 _aMeningococcal Vaccines
_xadministration & dosage
650 0 4 _aPoliovirus Vaccine, Inactivated
_xadministration & dosage
650 0 4 _aSingle-Blind Method
650 0 4 _aVaccines, Combined
_xadministration & dosage
700 1 _aWysocki, Jacek
700 1 _aBeeslaar, Johannes
700 1 _aEiden, Joseph
700 1 _aJiang, Qin
700 1 _aJansen, Kathrin U
700 1 _aJones, Thomas R
700 1 _aHarris, Shannon L
700 1 _aO'Neill, Robert E
700 1 _aYork, Laura J
700 1 _aPerez, John L
773 0 _tJournal of the Pediatric Infectious Diseases Society
_gvol. 5
_gno. 2
_gp. 180-7
856 4 0 _uhttps://doi.org/10.1093/jpids/piv064
_zAvailable from publisher's website
999 _c25662659
_d25662659